Loading
The bidirectional failure of heart and kidneys — one organ's dysfunction worsens the other.
CRS type 1 (acute): AKI after acute heart failure; type 2: chronic HF causing progressive CKD; type 4: CKD driving heart failure. Management is integrated: decongestion without worsening kidneys, RAAS/SGLT2i therapy at the right doses, and volume assessment. Outcomes are driven by both organs.
Excess extracellular fluid volume in kidney patients from inadequate excretion, causing edema, hypertension, pulmonary congestion, and increased cardiovascular risk.
A sudden drop in kidney function over hours to days - reversible if caught early, but a major risk factor for chronic kidney disease.
A diabetes drug (dapagliflozin, empagliflozin) that reduces kidney and heart risk in CKD even without diabetes.
A diuretic (furosemide, torsemide, bumetanide) that removes fluid in CKD and dialysis patients by blocking sodium reabsorption.
Advertisement
ZuvFlo is ready to integrate with your facility to streamline operations, automate compliance, and deliver better patient care.
No credit card required • Setup in under 2 hours • Cancel anytime
Advertisement
This content is a general reference, not medical advice, a diagnosis, or a treatment plan. Do not change your diet, fluids, medicines, or dialysis plan without your nephrologist or renal dietitian. Individual recommendations depend on your labs, medications, conditions, and care plan.